MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Bidirectional associations between seizures and parkinsonism: a retrospective case series

    Y. Chen, J. Fleisher, R. O'Dwyer (Chicago, USA)

    Objective: Within a single center, describe individuals with parkinsonism who develop seizures and vice versa based on epilepsy and movement disorders evaluation. Background: While neurodegeneration…
  • 2026 International Congress

    Investigating Hippocampal Subfield and Amygdala Volumes in Parkinson’s Disease with Anxiety

    Y. Feuozi, C. Lambert, G. Sheehan, C. Dore, A. Schrag (London, United Kingdom)

    Objective: To determine whether structural changes in the hippocampus and amygdala are associated with anxiety in Parkinson’s disease (PD), and to identify whether these alterations…
  • 2026 International Congress

    Integrating Multidisciplinary, Family-Centered Care to Optimize Functional Outcomes in Children with Cerebral Palsy.

    T. Voloshyn (TRUSKAVETS, Ukraine)

    Objective: Optimal management of Cerebral Palsy requires coordinated, evidence-based interventions that address both motor and non-motor domains across the lifespan.  Background: Randomized controlled trials (RCTs)…
  • 2026 International Congress

    Beyond Parkinson’s Disease, Impulse Control Dysregulation: The Psychosocial Correlates of Problematic Internet Use

    T. Adeoye, O. Buhari, O. Adeoye (Ogbomoso, Nigeria)

    Objective: To determine the prevalence of problematic internet use and associated psychosocial correlates as a phenotype of impulse control dysregulation among undergraduates. Background: Impulse control…
  • 2026 International Congress

    Early Caudate Dopaminergic Loss as an Imaging Biomarker of Cognitive Impairment in Parkinson’s Disease: A Longitudinal Analysis

    B. Panigrahi, D. Radhakrishnan, R. Rajan (Deoghar, India)

    Objective: The primary objective was to determine whether early pre-synaptic caudate denervation, measured using 123 I ioflupane SPECT quantitative metrics, provides independent and incremental prognostic value…
  • 2026 International Congress

    Cognitive Progression in Elderly Essential Tremor Patients: Evidence from an 18-Month Prospective Cohort

    E. Abed (Cairo, Egypt)

    Objective: Essential tremor (ET) is one of the most prevalent neurological disorders and has increasingly been linked to cognitive dysfunction. However, most existing data regarding…
  • 2026 International Congress

    Micro- and Nanoplastics in Parkinson’s Disease Pathogenesis An Emerging Environmental Risk Factor

    A. Aralbayeva, Z. Akhmetzhanova, A. Baidarbekova (Astana, Kazakhstan)

    Objective: To synthesize current experimental and translational evidence supporting the hypothesis that micro- and nanoplastics (MNPs) may contribute to Parkinson’s disease (PD) pathogenesis through neuroinflammatory…
  • 2026 International Congress

    Proposal of Anatomo-Functional Tremor Patterns for Ultrasound-Guided Botulinum Toxin Infiltration

    G. Salazar, I. Caballero (Terrassa, Spain)

    Objective: To propose a practical anatomo-functional framework for ultrasound-guided BoNT-A infiltration in upper limb tremor based on tremor biomechanics. Background: Botulinum toxin type A (BoNT-A)…
  • 2026 International Congress

    Skin Tau Quantification as a Potential Degeneration Biomarker in Parkinson’s Disease

    J. Rodriguez-Antiguedad, A. Puig-Davi, A. Vazquez-Oliver, E. Rivas-Asensio, E. Vacchi, G. Melli, L. Bojtos, C. Franch-Marti, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: This cross-sectional observational study aims to quantify total skin Tau levels in Parkinson’s disease (PD) patients and explore their association with clinical symptoms. Background:…
  • 2026 International Congress

    Repurposing Rifabutin for Neuro-Metabolic Disorders: AMPK-PGC-1α-Driven Mitochondrial Protection in Diabetes Associated Parkinsonism

    M I. Khan, D. Ahmed (PRAYAGRAJ, India)

    Objective: To assess the role of rifabutin in restoring mitochondrial function and energy balance through modulation of the AMPK–PGC-1α signaling pathway in diabetes-related Parkinsonism. Background:…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley